OLMA vs. TSHA
Compare and contrast key facts about Olema Pharmaceuticals, Inc. (OLMA) and Taysha Gene Therapies, Inc. (TSHA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: OLMA or TSHA.
Performance
OLMA vs. TSHA - Performance Comparison
Returns By Period
In the year-to-date period, OLMA achieves a -40.98% return, which is significantly lower than TSHA's 13.56% return.
OLMA
-40.98%
-31.40%
-10.10%
-41.69%
N/A
N/A
TSHA
13.56%
-0.50%
-32.32%
15.52%
N/A
N/A
Fundamentals
OLMA | TSHA | |
---|---|---|
Market Cap | $474.43M | $411.94M |
EPS | -$2.28 | $0.63 |
Total Revenue (TTM) | $1.88M | $9.92M |
Gross Profit (TTM) | $1.61M | $8.92M |
EBITDA (TTM) | -$135.54M | -$85.64M |
Key characteristics
OLMA | TSHA | |
---|---|---|
Sharpe Ratio | -0.64 | 0.11 |
Sortino Ratio | -0.73 | 1.04 |
Omega Ratio | 0.91 | 1.12 |
Calmar Ratio | -0.57 | 0.12 |
Martin Ratio | -1.76 | 0.34 |
Ulcer Index | 27.38% | 34.76% |
Daily Std Dev | 75.23% | 108.62% |
Max Drawdown | -96.26% | -98.14% |
Current Drawdown | -84.81% | -93.67% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between OLMA and TSHA is 0.29, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
OLMA vs. TSHA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Olema Pharmaceuticals, Inc. (OLMA) and Taysha Gene Therapies, Inc. (TSHA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
OLMA vs. TSHA - Dividend Comparison
Neither OLMA nor TSHA has paid dividends to shareholders.
Drawdowns
OLMA vs. TSHA - Drawdown Comparison
The maximum OLMA drawdown since its inception was -96.26%, roughly equal to the maximum TSHA drawdown of -98.14%. Use the drawdown chart below to compare losses from any high point for OLMA and TSHA. For additional features, visit the drawdowns tool.
Volatility
OLMA vs. TSHA - Volatility Comparison
The current volatility for Olema Pharmaceuticals, Inc. (OLMA) is 20.53%, while Taysha Gene Therapies, Inc. (TSHA) has a volatility of 50.33%. This indicates that OLMA experiences smaller price fluctuations and is considered to be less risky than TSHA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
OLMA vs. TSHA - Financials Comparison
This section allows you to compare key financial metrics between Olema Pharmaceuticals, Inc. and Taysha Gene Therapies, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities